(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ICP MEDS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ICP MEDS

ST13

US500000097976243

Class

10

Filing

97976243

Registration

7403651

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

05/28/2024

Trademark type

Word

Nice classes

10

Filing date

05/05/2022

Registration date

05/28/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/28/2024

Last transaction

05/28/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/17/2024

First use in commerce

04/17/2024

Drawing code

4

Owner type

03

Owner location

Largo, FL

Examiner

MASON,JARED MICHAEL

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Intercontinental Pharma Inc

Representatives

Ruth Khalsa THE IDEAS LAW FIRM, PLLC

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Surgical instrumentsscalpelsblades; Disposable syringes; Medical syringes

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/28/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/28/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/22/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/22/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/20/2024

IUAF

USE AMENDMENT FILED

04/18/2024

EISU

TEAS STATEMENT OF USE RECEIVED

04/18/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/20/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/26/2023

PUBO

PUBLISHED FOR OPPOSITION

12/26/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/06/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/20/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/12/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/12/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/12/2023

DPCC

DIVISIONAL PROCESSING COMPLETE

08/15/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/11/2023

DRRR

DIVISIONAL REQUEST RECEIVED

05/16/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/16/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/16/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/16/2023

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

05/16/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/23/2023

GNRT

NON-FINAL ACTION E-MAILED

02/23/2023

CNRT

NON-FINAL ACTION WRITTEN

02/23/2023

DOCK

ASSIGNED TO EXAMINER

02/23/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/10/2022

NWAP

NEW APPLICATION ENTERED

05/09/2022

Continuous trademark protection

Get notified about every new filing that threatens ICP MEDS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.